Nathanael Gray, Dana-Farber Cancer Institute, and Richard Young, Whitehead Institute, will be hosting the third Drugging Transcription conference on April 25, 2019 at the Boston Marriott Cambridge, 50 Broadway, Cambridge, MA.

The speakers assembled are leading academic and industry scientists who will cover cutting-edge areas of research in gene control and gene modulation to address key unmet clinical needs. Some of the topics that will be covered include: new insights into gene regulatory mechanisms, novel therapeutic targets and new approaches to gene modulation in disease.

For additional information, including full program and speaker biographies, please visit: transcription.wi.mit.edu

Sponsored by CAMP4 Therapeutics, Dewpoint Therapeutics, and Syros Pharmaceuticals